Clinical Trial: Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study

U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263451) titled 'Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study' on Nov. 24.

Brief Summary: This is a prospective, open-label, single-arm, exploratory clinical trial conducted at our institution to investigate the use of Irreversible Electroporation (IRE) for the treatment of breast cancer.

Study Start Date: Nov. 24

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: DEVICE: IRE by stunning pulse therapy device

Qualified patients will receive IRE ablation, followed by standard surgical resection for breast cancer.During the process, patients will be followed u...